ABOGENBIO Trademark
ABOGENBIO is a USPTO trademark filed by Suzhou Abogen Biosciences Co., Ltd.. Status: Registered.
Trademark Facts
| Mark | ABOGENBIO |
|---|---|
| Serial Number | 79329638 |
| Registration Number | 7862325 |
| Status | Registered |
| Filing Date | 2021-11-01 |
| Registration Date | 2025-07-15 |
| Mark Type | Stylized |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | Suzhou Abogen Biosciences Co., Ltd. |
| Attorney of Record | THOMAS HOXIE |
| Prosecution Events | 33 |
| Latest Event | FINO on 2026-02-19 |
Goods & Services
Pharmaceutical preparations for the treatment or prevention of cancer, and infectious diseases; chemico-pharmaceutical preparations for the treatment or prevention of cancer and infectious diseases; drugs being pharmaceutical preparations for medical purposes for the treatment or prevention of cancer and infectious diseases; biological preparations for the treatment or prevention of cancer and infectious diseases for medical purposes; medicines for the treatment or prevention of cancer and infectious diseases for human purposes; chemical preparations for medical purposes, namely, for the treatment or prevention of cancer and infectious diseases; crude drug being homeopathic pharmaceuticals for the treatment of infectious viral diseases;, lipid particle for nucleotide drug delivery purpose for the treatment or prevention of cancer and infectious diseases; and biochemical medicines for the treatment or prevention of cancer and infectious diseases; dietetic substances being foods and beverages adapted for medical use for the treatment or prevention of cancer and infectious diseases; Technological research in the field of medical research, specifically for the treatment or prevention of cancer and infectious diseases; quality control, specifically for products for the treatment or prevention of cancer and infectious disease; product quality testing, specifically for products for the treatment or prevention of cancer and infectious diseases; cancer research for medical purposes; pharmaceutical drug development services, specifically for pharmaceutical drugs for the treatment or prevention of cancer and infectious diseases; pharmaceutical product evaluation, namely, drug evaluation, specifically for the treatment or prevention of cancer and infectious diseases; pharmaceutical research services, specifically for products for the treatment or prevention of cancer and infectious diseases; medical research, specifically for the treatment or prevention of cancer and infectious diseases; development of pharmaceutical preparations and pharmaceuticals, specifically for products for the treatment or prevention of cancer and infectious diseases